Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JT002 in Adult Patients With Seasonal Allergic Rhinitis
NCT06861101Phase 2Completed
- Sponsor
- Shanghai Junshi Biosciences Co., Ltd.
- Start
- Feb 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JT002 in seasonal allergic rhinitis (SAR), sponsored by Shanghai Junshi Biosciences Co., Ltd.. Started Feb 2025; status: completed.
02
Drugs
JT002
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT06861101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06861101.